Advertisement

Topics

NHS England approves Kadcyla for routine use on NHS

19:00 EDT 18 Jun 2017 | Pharmaceutical Technology

NHS England has signed an agreement with Roche, which also received backing from NICE, to make the breast cancer drug Kadcyla available for routine use on the NHS.

Original Article: NHS England approves Kadcyla for routine use on NHS

NEXT ARTICLE

More From BioPortfolio on "NHS England approves Kadcyla for routine use on NHS"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...